FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2042084937> ?p ?o ?g. }

• W2042084937 endingPage "466" @default.
• W2042084937 startingPage "461" @default.
• W2042084937 abstract "Background Many studies have described the clinical effects of treating critical limb ischemia with granulocyte colony-stimulating factor-mobilized autologous peripheral blood mononuclear cells (M-PBMNC); however, there are no long-term data available on survival, limb salvage, or prognostic factors. Methods To investigate the long-term clinical outcomes of M-PBMNC implantation, we reviewed data for 162 consecutive patients with limb ischemia who were treated with M-PBMNC implantation at 6 hospitals between 2001 and 2006. A subset of 123 patients with homogenous clinical profiles was selected for prognostic factor analysis. Results Of the 162 patients, 50 died during the follow-up period. The median follow-up time for surviving patients was 26.4 months. The 2-year survival rate was 65% for the 140 patients with arteriosclerosis obliterans (ASO), and 100% for the 11, 4 and 7 patients with thromboangiitis obliterans (TAO), diabetic gangrene (DG) and connective tissue disease (CTD), respectively. The 1-year amputation-free rates for ASO, TAO, DG and CTD were 70%, 79%, 75% and 83%, respectively. Common serious adverse events included heart failure (15 cases), myocardial infarction (15 cases), serious infection (13 cases), stroke (10 cases), and malignant tumor (9 cases). Significant negative prognostic factors associated with overall survival were ischemic heart disease and collection of a small number of CD34-positive cells. Factors associated with time-to-amputation and amputation-free survival were a combination of Fontaine classification and lower limb gangrene, and history of dialysis. Conclusions Collection of a small number of CD34-positive cells and ischemic heart disease were associated with a reduction in overall survival." @default.
• W2042084937 created "2016-06-24" @default.
• W2042084937 creator A5006350361 @default.
• W2042084937 creator A5009924053 @default.
• W2042084937 creator A5016215778 @default.
• W2042084937 creator A5019045654 @default.
• W2042084937 creator A5033607838 @default.
• W2042084937 creator A5038359442 @default.
• W2042084937 creator A5040354154 @default.
• W2042084937 creator A5044882193 @default.
• W2042084937 creator A5054696863 @default.
• W2042084937 creator A5067382113 @default.
• W2042084937 creator A5076893733 @default.
• W2042084937 creator A5078467284 @default.
• W2042084937 date "2010-02-01" @default.
• W2042084937 modified "2023-10-14" @default.
• W2042084937 title "Long-term clinical outcomes for patients with lower limb ischemia implanted with G-CSF-mobilized autologous peripheral blood mononuclear cells" @default.
• W2042084937 cites W2021031710 @default.
• W2042084937 cites W2021573874 @default.
• W2042084937 cites W2042899052 @default.
• W2042084937 cites W2044609151 @default.
• W2042084937 cites W2060531063 @default.
• W2042084937 cites W2060548737 @default.
• W2042084937 cites W2064238921 @default.
• W2042084937 cites W2082154201 @default.
• W2042084937 cites W2096464735 @default.
• W2042084937 cites W2112267683 @default.
• W2042084937 cites W2115932678 @default.
• W2042084937 cites W2125030604 @default.
• W2042084937 cites W2160810667 @default.
• W2042084937 cites W4236938366 @default.
• W2042084937 doi "https://doi.org/10.1016/j.atherosclerosis.2009.07.050" @default.
• W2042084937 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19720375" @default.
• W2042084937 hasPublicationYear "2010" @default.
• W2042084937 type Work @default.
• W2042084937 sameAs 2042084937 @default.
• W2042084937 citedByCount "61" @default.
• W2042084937 countsByYear W20420849372012 @default.
• W2042084937 countsByYear W20420849372013 @default.
• W2042084937 countsByYear W20420849372014 @default.
• W2042084937 countsByYear W20420849372015 @default.
• W2042084937 countsByYear W20420849372016 @default.
• W2042084937 countsByYear W20420849372017 @default.
• W2042084937 countsByYear W20420849372018 @default.
• W2042084937 countsByYear W20420849372019 @default.
• W2042084937 countsByYear W20420849372020 @default.
• W2042084937 countsByYear W20420849372021 @default.
• W2042084937 countsByYear W20420849372023 @default.
• W2042084937 crossrefType "journal-article" @default.
• W2042084937 hasAuthorship W2042084937A5006350361 @default.
• W2042084937 hasAuthorship W2042084937A5009924053 @default.
• W2042084937 hasAuthorship W2042084937A5016215778 @default.
• W2042084937 hasAuthorship W2042084937A5019045654 @default.
• W2042084937 hasAuthorship W2042084937A5033607838 @default.
• W2042084937 hasAuthorship W2042084937A5038359442 @default.
• W2042084937 hasAuthorship W2042084937A5040354154 @default.
• W2042084937 hasAuthorship W2042084937A5044882193 @default.
• W2042084937 hasAuthorship W2042084937A5054696863 @default.
• W2042084937 hasAuthorship W2042084937A5067382113 @default.
• W2042084937 hasAuthorship W2042084937A5076893733 @default.
• W2042084937 hasAuthorship W2042084937A5078467284 @default.
• W2042084937 hasConcept C10205521 @default.
• W2042084937 hasConcept C126322002 @default.
• W2042084937 hasConcept C137061746 @default.
• W2042084937 hasConcept C141071460 @default.
• W2042084937 hasConcept C164705383 @default.
• W2042084937 hasConcept C185592680 @default.
• W2042084937 hasConcept C202751555 @default.
• W2042084937 hasConcept C2776204877 @default.
• W2042084937 hasConcept C2776626339 @default.
• W2042084937 hasConcept C2778486273 @default.
• W2042084937 hasConcept C2779464278 @default.
• W2042084937 hasConcept C2781099653 @default.
• W2042084937 hasConcept C28328180 @default.
• W2042084937 hasConcept C500558357 @default.
• W2042084937 hasConcept C54355233 @default.
• W2042084937 hasConcept C55493867 @default.
• W2042084937 hasConcept C71924100 @default.
• W2042084937 hasConcept C86803240 @default.
• W2042084937 hasConceptScore W2042084937C10205521 @default.
• W2042084937 hasConceptScore W2042084937C126322002 @default.
• W2042084937 hasConceptScore W2042084937C137061746 @default.
• W2042084937 hasConceptScore W2042084937C141071460 @default.
• W2042084937 hasConceptScore W2042084937C164705383 @default.
• W2042084937 hasConceptScore W2042084937C185592680 @default.
• W2042084937 hasConceptScore W2042084937C202751555 @default.
• W2042084937 hasConceptScore W2042084937C2776204877 @default.
• W2042084937 hasConceptScore W2042084937C2776626339 @default.
• W2042084937 hasConceptScore W2042084937C2778486273 @default.
• W2042084937 hasConceptScore W2042084937C2779464278 @default.
• W2042084937 hasConceptScore W2042084937C2781099653 @default.
• W2042084937 hasConceptScore W2042084937C28328180 @default.
• W2042084937 hasConceptScore W2042084937C500558357 @default.
• W2042084937 hasConceptScore W2042084937C54355233 @default.
• W2042084937 hasConceptScore W2042084937C55493867 @default.
• W2042084937 hasConceptScore W2042084937C71924100 @default.
• W2042084937 hasConceptScore W2042084937C86803240 @default.
• W2042084937 hasIssue "2" @default.

• next